LIBERATOR MEDICAL HOLDINGS, INC.
Consumer Discretionary · Retail-Drug Stores and Proprietary Stores · NV · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | |
|---|---|---|---|---|---|---|
| Revenue | $81.6M | $74.6M | $69.1M | $60.9M | $52.7M | $40.9M |
| Operating income | $11.9M | $12.7M | $11.8M | $4.3M | $2.6M | $4.6M |
| Net income | $7.3M | $7.8M | $7.1M | $2.5M | $259,000 | $2.6M |
| Total assets | $62.6M | $54.3M | $49.1M | $42.9M | $35.4M | $30.2M |
| Total liabilities | $28.9M | $21.9M | $19.3M | $15.9M | $11.1M | $11.8M |
| Equity | $33.7M | $32.4M | $29.8M | $27.0M | $24.3M | $18.4M |
| EPS (diluted) | $0.14 | $0.15 | $0.14 | $0.05 | $0.00 | $0.05 |
| Shares out. | 53.9M | 53.2M | 52.4M | 48.1M | 48.1M | 44.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2015- Operating margin
- 14.6%
- Net margin
- 9.0%
- Return on equity
- 21.7%
- Return on assets
- 11.7%
- Return on capital (ROCE)
- 25.9%
- Liabilities / assets
- 46.1%
- Debt / equity
- 0.86×
- Book value / share
- $0.63
- Revenue growth (YoY)
- 9.4%
- Net income growth (YoY)
- −6.3%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2015- Altman Z″ (distress)
- 3.72safe
- Accruals / assets
- 5.8%moderate
- Beneish M-Score
- -2.10normal
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 6 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Feb 14, 2011
- NT 10-Kmissed a reporting deadline ↗Dec 29, 2010
- NT 10-Kmissed a reporting deadline ↗Dec 27, 2007
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2007
- NT 10-Qmissed a reporting deadline ↗May 16, 2007
- NT 10-Qmissed a reporting deadline ↗May 16, 2006
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Shareholder voteJan 21, 2016
- Other material eventJan 7, 2016
- Entered a material agreementDec 23, 2015
- Results of operationsDec 15, 2015
- Entered a material agreement · Director / officer change · Other material eventNov 20, 2015
- Shareholder vote · Other material eventSep 11, 2015
- Results of operationsAug 11, 2015
- Results of operationsMay 12, 2015
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13D/ALIBERATOR MEDICAL HOLDINGS, INC. AMENDMENT NO. 1Feb 1, 2016
- 15-12GFeb 1, 2016
- SC 13D/AJan 26, 2016
- 4OWNERSHIP DOCUMENTJan 22, 2016
- 4OWNERSHIP DOCUMENTJan 22, 2016
- 4OWNERSHIP DOCUMENTJan 22, 2016
- 4OWNERSHIP DOCUMENTJan 22, 2016
- 4OWNERSHIP DOCUMENTJan 22, 2016
- 4OWNERSHIP DOCUMENTJan 22, 2016
- 4OWNERSHIP DOCUMENTJan 22, 2016
- 25-NSEJan 22, 2016
- 4FORM 4 SUBMISSIONJan 21, 2016
- SC 13D/ASCHEDULE 13D AMENDMENT NO. 1Jan 21, 2016
- S-8 POSPOST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8Jan 21, 2016
- 8-KFORM 8-K CURRENT REPORTJan 21, 2016
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.